Update of HPV-associated female genital cancers in the United States, 1999-2004

Journal of Women's Health

Volumn 18, Issue 11, 2009, Pages 1731-1738

  Watson, Meg ^a   Saraiya, Mona ^a   Wu, Xiaocheng ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Louisiana Tumor Registry   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER REGISTRY; CHILD; ETHNICITY; FEMALE; GYNECOLOGIC CANCER; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; UTERINE CERVIX CANCER; VULVA CANCER; WART VIRUS;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; ETHNIC GROUPS; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; NEOPLASM INVASIVENESS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PROGNOSIS; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VAGINAL NEOPLASMS; VULVAR NEOPLASMS; WOMEN'S HEALTH; YOUNG ADULT;

EID: 71449083807     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2009.1570     Document Type: Article

References (20)

1. Walboomers JMM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19.
2. Parkin DM, Bray F. The burden of HPV-related cancers. Vaccine 2006;24(Suppl 3):S11-S25.
3. Munoz N, Castellsague X, de Gonzalez AB, Gissmann L. HPV in the etiology of human cancer. Vaccine 2006;24(Suppl 3):S1-S10.
4. Insinga RP, Liaw KL, Johnson LG, Madeleine MM. A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States. Cancer Epidemiol Biomarkers Prev 2008;17:1611-1622.
5. U.S. Food and Drug Administration. FDA approves expanded uses for Gardasil to include preventing certain vulvar and vaginal cancers. FDA, U.S. Department of Health and Human Services, 2008. www.fda.gov=NewsEvents= Newsroom=PressAnnouncements=2008=ucm116945.htm. Accessed April 27, 2009.
6. Watson M, Saraiya M, Ahmed F, et al. Using populationbased cancer registry data to assess the burden of HPVassociated cancers in the U.S.: Overview of methods. Cancer 2008;113:2841-2854.
7. U.S. Cancer Statistics Working Group. United States cancer statistics: 2004 incidence and mortality. Atlanta: Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, 2007.
8. Espey DK, Wiggins CL, Jim MA, Miller BA, Johnson CJ, Becker TM. Methods for improving cancer surveillance data in American Indian and Alaska Native populations. Cancer 2008;113:1120-1130.
9. NAACCR Latino Research Work Group. NAACCR guideline for enhancing Hispanic-Latino identification: Revised NAACCR Hispanic=Latino identification algorithm [NHIA v2]. Springfield, IL: North American Association of Central Cancer Registries, 2005.
10. Tiwari RC, Clegg LX, Zou Z. Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res 2006;15: 547-569.
11. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation test for Joinpoint regression with applications to cancer rates. Stat Med 2000;19:335-351 (correction: 2001;20:655).
12. Tangka FK, O'Hara B, Gardner JG, et al. Meeting the cervical cancer screening needs of underserved women: The performance of the National Breast and Cervical Cancer Early Detection Program. Cancer Epidemiol Biomarkers Prev 2009;12: in Press.
13. Becker TM, Espey DK, Lawson HW, Saraiya M, Jim MA, Waxman AG. Regional differences in cervical cancer incidence among American Indians and Alaska Natives, 1999-2004. Cancer 2008;113:1234-1243.
14. Breast and Cervical Cancer Prevention and Treatment Act of 2000. Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion 2008. Available at www.cdc.gov=cancer=nbccedp= legislation=law106-354.htm
15. Saraiya M, Watson M, Wu X, et al. Incidence of in situ and invasive vulvar cancer in the U.S., 1998-2003. Cancer 2008; 113:2865-2872.
16. U.S. Cancer Statistics Working Group. United States cancer statistics: 1999-2005. Incidence and mortality web-based report. Centers for Disease Control and Prevention and National Cancer Institute, 2009. Available at www.cdc.gov= cancer=npcr=uscs= Accessed October 23, 2007.
17. Saraiya M, Goodman MT, Datta SD, Chen VW, Wingo PA. Cancer registries and monitoring the impact of prophylactic HPV vaccines: The potential role. Cancer 2008;113:3047-3057.
18. Smith JS, Backes DM, Hoots BE, Kurman RJ, Pimenta JM. Human papillomavirus type distribution in vulvar and vaginal cancers and their associated precursors. Obstet Gynecol 2009;113:917-924.
19. Bliss A. Racial misclassification of American Indians in the Oklahoma Central Cancer Registry. Counting the undercounted: Finding and using data to serve disparate populations. 2009 Collaborative NCCCP & NPCR Conference. April 15, 2009.
20. Atlanta, GA, Merrill RM. Impact of hysterectomy and bilateral oophorectomy on race-specific rates of corpus, cervical, and ovarian cancers in the United States. Ann Epidemiol 2006; 16:880-887.